312 555 6296

Menu

Category: General

Strawberry shortcake

Source…

Johns Hopkins Scientists Chart How Brain Signals Connect to Neurons

Scientists at Johns Hopkins have used supercomputers to create an atomic scale map that tracks how the signaling chemical glutamate binds to a neuron in the brain. The findings, say the scientists, shed light on the dynamic physics of the chemical’s pathway, as well as the speed of nerve cell communications.
Source…

Dental Exam

Source: National Library of Medicine – Related MedlinePlus Pages: Child Dental Health, Dental Health, Gum Disease, Tooth DecaySource…

Sunless tanning: What you need to know

Source…

Exposure to Larger Air Particles Linked to Increased Risk of Asthma in Children

Researchers at The Johns Hopkins University report statistical evidence that children exposed to airborne coarse particulate matter — a mix of dust, sand and non-exhaust tailpipe emissions, such as tire rubber — are more likely to develop asthma and need emergency room or hospital treatment for it than unexposed children.
Source…

Women Have a Higher Risk of Stroke

Source: American Stroke AssociationRelated MedlinePlus Pages: StrokeSource…

Diabetes symptoms: When diabetes symptoms are a concern

Diabetes symptoms are often subtle. Pay attention to the clues your body’s giving you. Source…

How Electroconvulsive Therapy Relieves Depression Per Animal Experiments

In a study using genetically engineered mice, Johns Hopkins researchers have uncovered some new molecular details that appear to explain how electroconvulsive therapy (ECT) rapidly relieves severe depression in mammals, presumably including people. The molecular changes allow more communication between neurons in a specific part of the brain also known to respond to antidepressant drugs.Source…

Study Connects Dots Between Vaginal Birth, Pelvic Floor Disorder

Related MedlinePlus Pages: Childbirth, Pelvic Floor DisordersSource…

More Tumor Mutations Equals Higher Success Rate With Cancer Immunotherapy Drugs

The “mutational burden,” or the number of mutations present in a tumor’s DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by Johns Hopkins Kimmel Cancer Center researchers shows. The finding, published in the Dec. 21 New England Journal of Medicine, could be used to guide future clinical trials for these drugs.
Source…